8-K ·Filed Jul 22, 2026

SUPN

SUPERNUS PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago SEC0001356576-26-000031
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

This is a routine earnings date announcement with no actionable information. Monitor the Q2 2026 earnings release on August 4, 2026 for actual financial results and any guidance updates.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
SUPN ▲ +0.55% at T+20d
NEUTRAL call ✓ call won +0.55% · α vs SPY -2.76% · entry $47.19 → $47.45
Next anchor: T+60d in 13d
Latest observation: T+49 +0.94% FF3 residual α
Entry anchored
Jul 22, 03:59 PM ET
via exchange tick
T+1d
-2.10%
call -2.10% · α -2.20%
$46.20
settled 2mo ago
T+5d
-3.35%
call -3.35% · α -3.82%
$45.61
settled 2mo ago
T+20d
+0.55%
call +0.55% · α -2.76%
$47.45
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

Supernus Pharmaceuticals filed an 8-K on July 22, 2026, solely to announce the date of its Q2 2026 earnings release and conference call scheduled for August 4, 2026. The filing contains no financial results, guidance updates, or material business developments — it is a routine administrative notification of the earnings date.

Key Facts

  • Company will report Q2 2026 results after market close on August 4, 2026.
  • Conference call and webcast scheduled for August 4, 2026 at 4:30 p.m. ET.
  • No financial data, guidance changes, or material events disclosed in this filing.

Financial Impact

No financial data disclosed in this filing.

Risk Factors

  • No new risks disclosed in this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001356576-26-000031
Exhibit: ex-99107x22xearningscallan.htm0001356576-26-000031
Document: 0001356576-26-000031-index-headers.html0001356576-26-000031
Document: 0001356576-26-000031-index.html0001356576-26-000031
Document: 0001356576-26-000031.txt0001356576-26-000031
8-K Data (Synthetic)0001356576-26-000031
20 reports for SUPN
Performance horizon
75% Hit rate 6 of 8 directional calls best @ T+1▲ +8.46%Aug 3, 2026
Filters
Rows
Reports for SUPN — sortable, filterable
TypeNow
Sep 11, 2026
20d ago
DEFM14A
MIXED ★ 7/10
$41.49 $42.78▲ +3.11%▲ +3.00%$42.60 (+2.68%)
Aug 3, 2026
8w ago
DEFA14A / 425
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$42.60 (−1.50%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$42.60 (−1.50%)
Aug 3, 2026
8w ago
DEFA14A / 425
BULLISH ★ 8/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.60 (−7.39%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 7/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.60 (−7.39%)
Aug 3, 2026
8w ago
8-K
MIXED ★ 7/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.60 (−7.39%)
Aug 3, 2026
8w ago
DEFA14A / 425 / 8-K
BULLISH ★ 8/10
$46.00 $47.07▲ +2.33%▲ +0.30%$42.60 (−7.39%)
Jul 22, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$47.19 $45.61▼ −3.35%▼ −3.82%$42.60 (−9.73%)
Jul 22, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$47.19 $45.61▼ −3.35%▼ −3.82%$42.60 (−9.73%)
Jul 20, 2026
10w ago
Court Ruling
NEUTRAL ★ 3/10
$47.42 $46.20▼ −2.57%▼ −2.15%$42.60 (−10.16%)
Showing 10 of 20

US Market Status

Market Open — Closes in 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access